Ayurvedic Nanoformulations for the Management of Diabetes Mellitus
Abstract
Diabetes mellitus remains a global health challenge, necessitating innovative therapeutic approaches that combine traditional knowledge with modem advancements. Ayurveda, with its rich repository of medicinal herbs and holistic treatment principles, offers promising solutions, particularly when integrated with nanotechnology to enhance bioavailability and efficacy. This systematic literature review examines the current state of research on Ayurvedic nanoformulations for diabetes management, focusing on their development, mechanisms, and therapeutic outcomes. We analyze the convergence of Ayurvedic nanomedicine and technology, the role of specific herbs and their bioactive compounds, and the methodologies employed in formulating and evaluating these nanoformulations. The review synthesizes evidence from peer-reviewed studies to identify trends, gaps, and future directions in this interdisciplinary field. Our findings reveal that Ayurvedic nanoformulations, such as those incorporating Gymnema sylvestre, Momordica charantia, and Curcuma longa, demonstrate significant potential in improving glycemic control and mitigating diabetic complications through targeted delivery and sustained release. However, challenges related to standardization, scalability, and clinical validation persists, highlighting the need for rigorous research and collaborative efforts between traditional and modern scientific communities. The study concludes that Ayurvedic nanoformulations represent a viable complementary strategy for diabetes management, provided that further investigations address existing limitations and optimize their therapeutic potential. This review serves as a comprehensive resource for researchers and practitioners interested in the intersection of Ayurveda and nanotechnology for diabetes care.
Downloads
References
2. Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine. 2019.
3. Khursheed R, Singh SK, Wadhwa S, Kapoor B, et al. Treatment strategies against diabetes: success so far and challenges ahead. Eur J Pharmacol. 2019.
4. Verma SK, Pandey M, Sharma A, Singh D. Exploring Ayurveda: principles and their application in modern medicine. Bull Natl Acad Med Sci (India). 2024.
5. Thottapillil A, Kouser S, Kukkupuni SK, et al. An “Ayurveda-Biology” platform for integrative diabetes management. J Ethnopharmacol. 2021.
6. Kumar R. Opportunities and limitations in globalising Ayurveda. In: Ayurveda at the Crossroads of Care and Cure. 2001.
7. Emeje MO, Obidike IC, Akpabio EI, et al. Nanotechnology in drug delivery. 2012.
8. Shree JN, Anuf AR, Ahmad S. Comparative analysis of traditional and nano-formulated approaches in viability, targeted delivery, and patient outcomes. Herbal Pharmacopoeia. 2025.
9. Valikarimwala M, Gadale S, et al. Applications of nanotechnology in Ayurveda: a review. Res Rev Biotechnol. 2021.
10. Sunita, Kaushik R, Verma KK, Parveen R. Herbal nanoformulations for diabetes: mechanisms, formulations, and clinical impact. Curr Diabetes Rev. 2025.
11. Bhadouria N, Alam A, Kaur A. Nanotechnology-based herbal drug formulation in the treatment of diabetes mellitus. Curr Diabetes Rev. 2025.
12. Pal D, Gurjar VK. Nanometals in bhasma: Ayurvedic medicine. In: Nanoparticles in Pharma. 2017.
13. Paul S, Chugh A. Assessing the role of Ayurvedic bhasmas as ethno-nanomedicine in the metal-based nanomedicine patent regime. J Intellect Prop Rights. 2011.
14. Pal SK. The Ayurvedic bhasma: the ancient science of nanomedicine. Recent Pat Nanomed. 2015.
15. Subedi RP, Vartak RR, Kate PG. Study of general properties of Abhrak Bhasma: a nanomedicine. Int J Pharm Sci Rev Res. 2017.
16. Pal D, Sahu CK, Haldar A. Bhasma: the ancient Indian nanomedicine. J Adv Pharm Technol Res. 2014.
17. Phogat J, Sunder S, Sethi S, Singh J, et al. Exploring the role of curcumin and nanoformulations in wound healing. IJCRT Res J. 2025.
18. Chauhan A, Gaur R, Kanta C. Nano formulation of berberine: transforming a natural alkaloid into advanced therapeutics. J Appl Pharm Sci. 2024.
19. Wavare RC, Kadam VV, Sheth SM, et al. Physicochemical standardization of traditional medicine Mukta Bhasma in nanoparticles. Asian J Pharm Res Dev. 2014.
20. Tyeb S, Kumar N, Verma V, Kumar A, Kaul S. Synergistic Tamra-Yasad Bhasma and cinnamaldehyde nano-shield hydrogels for diabetic wound repair. Mater Adv. 2026.
21. Lababidi JM, Azzazy HMES. Saussurea costus in nanomedicine: green-synthesized metal nanoparticles and advanced nanosystems for enhanced therapeutic efficacy. RSC Adv. 2026.
22. Sharma R, Prajapati PK. Nanotechnology in medicine: leads from Ayurveda. J Pharm Bioallied Sci. 2016.
23. Chakrapany S, Chandan S. Nanocarriers of novel drug delivery systems for Ayurveda herbal remedies: need of the hour. 2014.
24. Kathole KS, Hatwar PR, Bakal RL, et al. Nanotechnology-based drug delivery systems and herbal medicine. 2025.
25. Perera B, Goonaratna C, et al. Efficacy and safety of an Ayurveda herbal formulation in uncomplicated type 2 diabetes mellitus. J Evid Based Complementary Altern Med. 2025.
26. Sharma N, Bora KS, Kumar A. Holistic care management for diabetes mellitus: a futuristic approach. J Med Pharm Allied Sci. 2023.
27. Chowdhury MAH, Al Araby SQ, Alelwani W, Kattan SW, et al. Green-synthesized nanoparticles of polyherbal extract attenuate pancreatic β-cell necrosis in diabetic models. Heliyon. 2023.
28. Majhi L, Shah SASR. Exploring Shilajatu’s therapeutic potential in diabetes management. Int J Sci Res. 2024.
29. Umrani RD, Agrawal DS, Paknikar KM. Anti-diabetic activity and safety assessment of Jasada Bhasma (zinc ash) in rats. Indian J Exp Biol. 2013.
30. Chavan AB, Goyal S, Patel AM. Formulation of silver nanoparticles using Gymnema sylvestre leaf extract and in vitro anti-diabetic activity. J Pharm Res Int. 2022.
31. Ponnusamy S, Zinjarde S, Bhargava S, Kumara AR. Role of Curcuma longa in diabetes. 2012.
32. Potphode ND, Daunde JA, Desai SS, Walvekar MV. Nano-curcumin: a potent enhancer of antioxidant systems in diabetic mice. Int J Phytomed. 2018.
33. Ota S, Dua P, Sahu DS, Sharma SK, et al. Clinical safety of selected Ayurvedic formulations in diabetes mellitus. J Res Ayurvedic Sci. 2018.
34. Afify M, Samy N, Hafez NA, et al. Evaluation of zinc oxide nanoparticles in diabetes treatment in rats. Egypt J Chem. 2019.
35. Manna K, Mishra S, Saha M, Mahapatra S, et al. Amelioration of diabetic nephropathy using gold nanoparticles. Int J Nanomedicine. 2019.
36. Satpathy B, Sa N, Behera A, Sahu PK. Dose-dependent attenuation of Clitoria ternatea efficacy by cobalt oxide nanoparticles. Mol Neurobiol. 2025.
37. Meenakshi N, Angayarkanni R, Archana A. Anti-diabetic effect of green-synthesized silver nanoparticles of Piper betle. Asian J Pharm Clin Res. 2022.
38. Raghunath I, Koland M, Saoji SD, Bukke SPN, et al. Effects of piperine on insulin-loaded nanoparticles. Sci Rep. 2025.
39. Gaikwad S, Vora S, Bansode A, Garje V, Bhaiya S, et al. Green synthesis of metal oxide nanoparticles for diabetes treatment. BioNanoScience. 2023.
40. Rokkarukala S, Cherian T, Ragavendran C, et al. Gold nanoparticles from marine soft coral for antidiabetic activity. Heliyon. 2023.
41. Chauhan A, Semwal DK, Mishra SP, et al. Ayurvedic research and methodology: present status and future strategies. AYU. 2015.
42. Chauhan A, Semwal DK, Joshi SK. Biotechnological applications in Ayurveda. Curr Tradit Med. 2023.
43. Arora S, Samanta K, Chettri S, Rawat D, et al. Ashwagandha: a flagship herb from past to nano era. Int J Pharm Investig. 2023.
44. Kaushik D, Tanwar A, Davis J. Ethnopharmacological and phytochemical studies of Tridax procumbens. 2020.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
.